Submitted by Anonymous (not verified) on 26 November 2025 - 15:15
Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Date of authorisation: 08/05/2017, Revision: 18, Status: Authorised
Source: